期刊名称：MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
 期刊简介(About the journal)
编辑部信息(Editorial Board)
About the journal
Focus and Scope
Reciprocal interdependence between infectious and hematologic diseases (malignant and non-malignant) is well known. This relationship is particularly evident in Mediterranean countries. Parasitosis as Malaria, Leishmaniosis, B Hookworms, Teniasis, very common in the southeast Mediterranean area, infect about a billion people and manifest prevalently with anemia so that they are usually diagnosed mostly by experienced hematologist on blood or bone marrow smear. On the other hand, infections are also a significant problem in patients affected by hematological malignancies. The blood is the primary vector of HIV infection, which otherwise manifest with symptoms related to a reduction in T lymphocytes. In turn, infections can favor the insurgency of hematological malignancies. The causative relationship between Epstein-Barr virus infection, Helicobacter pylori, hepatitis C virus, HIV and lymphoproliferative diseases is well known.
Editorials from editors (specialist in hematology and infectious diseases) or comments will be welcomed to highlight particularly relevant articles appeared on this journal or in the more prestigious international journals. MJHID will be a leading journal on subjects of current importance in clinical hematology and infectious diseases. Every issue would have, besides the editor in chief, a guest editor. Both editors provide to invite experts on the selected topic to perform a complete update of the arguments readily available for practicing physician. The journal will also have a section devoted to original papers, which will be distinguished in Full articles, Scientific letter, Educational, clinical case, Case Reports and Letters to Editor.
Publication of Case Reports is not a primary scope of this Journal and will represent a limited quote of papers published. They will be considered when they significantly expand the field of general medical knowledge and/or contribute to acknowledging the pathophysiology of the disease. The rarity of the disease is not considered a criterium of priority. Case reports of a puzzling diagnosis, well documented and having a prevalent educational character will be assigned to the section MJHID Educational Clinical Case. Clinical trials of hematological and infectious diseases of Mediterranean area will have their natural home in this Journal. Papers with translational research strictly correlated to clinical problems will also be considered.
Peer Review Process
Our journal follows the COPE Code of Conduct and Best Practice Guidelines for Journal Editors. The articles are reviewed by two external reviewers and by the Editor in Chief/Guest Editor or a member of the Editorial Board. Authors can suggest 2 or more reviewers; moreover, in any case, the Editor in Chief or/and the Guest Editor will peer review all the manuscripts. Furthermore, two reviewers will be consulted. If the reviewers are in disagreement, a third reviewer will be asked. In any case, the final decision will be made by the editor. The first decision will be taken within six weeks. If the author is unhappy with the decision, he can propose an independent reviewer, with proved experience in the field (Publications in peer review journals).
Publication Frequency
All the articles will be published in small groups as soon as they are ready, by adding them to the "current" volume, every two months. Two topical reviews series having one or two guest editors will be planned every year. The items concerning the reviews series will be published when accepted, and then collected at the end of the year to be found together also on their own site.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.Starting from 1-1-2019, all articles, excluding Reviews by invited authors, will be processed after receiving a subscribed declaration by the authors they undertake to pay a fee of 600,00 € (+ VAT, if any) in case of acceptance for publication. The Article Processing Charges will have to be paid to the Publisher; instructions are given in the Journal’s Guidelines (https://mattiolihealth.com/shop/publication-fee-mediterranean-journal-of-hematology-and-infectious-diseases/) The Editorial Board of the Mediterranean Journal of Hematology and Infectious Diseases is engaged in improving the quality of the papers published in our journal. So, with the agreement of the Publisher, the possibility of publishing in MJHID without charge will be extended to the authors of the five papers which obtained the most citations which contributed to Impact Factor of the year throughout the two years following.
Mediterranean Journal of Hematology and Infectious Diseases
Editor in Chief: Giuseppe Leone, Rome, Italy
The Journal publishes original articles and reviews concerning both clinical hematology and infectious diseases. Particular attention will be reserved for original manuscripts focusing on the relationship between blood and infectious diseases. Authors of reviews-articles of relevant and timely subjects are solicited by the Editor in Chief or by the Guest Editor of Reviews Series. However, Authors, who have reputed original publications in journals covered by SCOPUS and or Web of Science on the field, can submit a review article independently, but they should previously send a summary to the Editor in Chief obtaining his approval. In any case, any manuscript will be submitted to revision and could be rejected. The number of authors of the original papers should not be more than seven. Only papers reporting clinical data of many cooperative groups could have a number of authors superior.
Scientific Letters: We encourage the submission of significant new findings that fit into the format of a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. The initial statement of this paragraph will be utilized as abstract and headline. Scientific Letters have a maximum of 2000 words in the text (excluding title, affiliations, figures legends or references), a maximum of 3 tables and/or figures, and only 20 essential references. Letters will appear in the table of contents, have a DOI and be indexed in PubMed. The number of authors should not be more than 5.
CLINICAL CASES
Clinical cases represent a fixed and limited quote of MJHID publications and are published in different sections.
Case reports describe one to three patients or a single family. They are taken into consideration only when expanding the field of general medical knowledge and/or physiopathology of the disease. The rarity of the case is not regarded as a criterium of priority. The number of authors should not be more than four.
Educational Clinical Cases. In this section, the MJHID presents clinical cases with a puzzling diagnosis, clarified step by step with appropriate documentation. The number of authors should not be more than four
Letter to Editor. Letters to the Editor may be used in primis to comment articles appeared in MJHID and to give an opinion or suggestions about topics recently treated in the MJHID, giving original data. Only clinical cases referring to previously published full papers in MJHID can be taken into consideration as a letter to Editor. The number of authors should not be more than three.
Journal History
The Mediterranean Journal of Hematology and Infectious Diseases has been founded by Giuseppe Leone, Professor of Hematology at the Catholic University of Rome in 2009, with the Collaboration of Prof. Eligio Pizzigallo, Infectivologist, and Luigi Maria Larocca, Pathologist.
The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006]
is owned by the U.C.S.C. and it is published by Mattioli 1885, Fidenza, Italy.
The MJHID is indexed and abstracted in Science Citation Index Expanded
and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.
Editorial Board
Editor in Chief
Prof. Giuseppe Leone, Editor in Chief Catholic University, Rome, Italy
Deputy Editor
Dr. Luciana Teofili, Italy
Coeditors
Dr. Luciana Teofili, Italy
Prof. Eligio Pizzigallo, "G. d'Annunzio" University of Chieti (IT), Italy
Prof. Francesco Lococo, Università di Roma TorVergata, Roma, Italy
Dr. Corrado Girmenia, Università "La Sapienza". Roma, Italy
Prof. Livio Pagano, Università Cattolica, Italy
Prof. Giovanni de Gaetano, "John Paul II" Centre for High Technology Research, Italy
Prof. Luigi Maria Larocca, Catholic University, Rome, Italy
Editorial Board
Dr. Thomas V. Adamkiewicz, Morehouse School of Medicine, Atlanta, GA 30344, USA
Prof. Wassim Y Almawi, Faculty of Sciences El Manar University Tunis, Tunisia, Tunisia
Prof. Lodovico Balducci, Moffit Cancer Center, United States
Dr. Samir Ballas, Cardeza Foundation for Hematologic Research, Philadelphia.
Dr. Michele Bibas, Dipartimento clinico e di ricerca clinica, Ematologia - INMI "Lazzaro Spallanzani" IRCCS ROME, Italy
Prof. Maria Domenica Cappellini, University of Milan, Milan, Italy
Prof. Carmelo Carlo-Stella, Humanitas Research Hospital & University of Milano, Italy
Dr. Mammen Chandy, Tata Medical Center. Kolkata, India.
Dr. Raffaella Colombatti, Clinic of Pediatric Hematology-Oncology, Department of Pediatrics, Azienda Ospedaliera-Università di Padova, Padova, Italy., Italy
Prof. Giovanni Delogu, Institute of Microbiology, Catholic University, Rome, Italy., Italy
Ass. prof. Ilker Devrim, Dr.Behcet Uz Chıldrens Hospital, Turkey
Dr. Dimitar Efremov, International Center for Genetic Engineering & Biotechnology, Monterotondo Scalo, Italy
Prof. Mohssen Elalfy, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Egypt
Dr. Prof. Alison Freifeld, Alison Freifeld MD Professor, Internal Medicine Infectious Diseases Section University of Nebraska Medical Center Omaha, NE 68198-5400 402-559-8668
Prof. Gianluca Gaidano, University of Eastern Piedmont .Novara, Italy
Prof. Andrea Gallamini, Department of Research, Innovation and Statistics, A. Lacassagne Cancer Centre, Nice France, Italy
Dr. Kanjaksha Ghosh, National Institute Of Immunohaematology. ( ICMR )
Dr. Prof. Andreas H. Groll,, MD, Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, Children's University Hospital, Albert-Schweitzer-Campus 1, Building A1, Münster 48149, Germany. Tel.: +49 251 834 7742. Fax: +49 251 834 7828. E-mail:, Germany
Prof. Olivier Hermine, Hopital Necker, Paris, France
Prof. Hee-Je Kim, Department of Hematology, Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Korea, Republic of
Dr. Stefan Hohaus, Catholic University, Italy
Prof. Sanaa Kamal, Ain Shams University/Tufts Medical School, United States
Prof. Giorgio La Nasa, Università di Cagliari., Italy
Prof. Richard A. Larson, University of Chicago, United States
Dr. Antonio Maria Leone, Università Cattolica del Sacro Cuore Roma, Italy
Prof. Lucio Luzzatto, Istituto Toscano Tumori, Firenze, Italy
Dr. Maurizio Martini, Università Cattolica del Sacro Cuore, Roma, Italy
Dr. Annarita Migliaccio, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Dr. Janos Minarovits, Microbiological Research Group, National Center for Epidemiology, Hungary
Prof. Moshe Mittelman, Department of Medicine, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel, Israel, Israel
Prof. Raffaella Origa, Clinica Pediatrica 2°, Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Università di Cagliari, Ospedale Regionale per le Microcitemie, ASL 8 Cagliari, Italy
Prof. Eliezer A. Rachmilewitz, Medicine and Pediatrics, Presbyterian Hospital, New York Cornell University, New York, NY, USA
Prof Josep-Maria Ribera, Clinical Hematology Department ICO-Hospital Germans Trias i Pujol Jose Carreras Research Institute Badalona, Spain, Spain
Dr. Deborah Rund, Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel
Prof. Miguel A. Sanz, Hospital Universitario La Fe Servicio de Hematología Valencia, Spain, Spain
Prof. Simona Sica, Università Cattolica del Sacro Cuore. Roma, Italy
Dr George Vassilopoulos, University of Thessaly Medical School, Greece
Prof. Adriano Venditti, Università Roma Torvergata, Italy
Dr. Lorenzo Zammarchi, Infectious Diseases Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Italy
Past and Present Guest Editors
Prof Sergio Amadori, Università Torvergata, Roma, Italy
Prof. Luca Arcaini, Luca Arcaini, MD, Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy. E-mail: luca.arcaini@unipv.it
Prof. Giuseppe Avvisati, Capus Biomedico, Italy
Prof. Michele Baccarani
Prof. Lodovico Balducci, Moffit Cancer Center, United States
Prof. Renato Bassan
Prof. Maria Domenica Cappellini, University of Milan, Milan, Italy
Prof. Giancarlo Castaman, Italy
Prof. Francesco Castelli, University of Brescia Clinic of Infectious Diseases
Prof. Roberto Cauda, Istituto Clinica Malattie Infettive.Università Cattolica.Roma, Italy
Dr. Chiara Cerletti
Prof. Giovanni de Gaetano, "John Paul II" Centre for High Technology Research, Italy
Prof. Valerio De Stefano, Università Cattolica del Sacro Cuore
Dr. Dimitar Efremov, International Center for Genetic Engineering & Biotechnology, Monterotondo Scalo, Italy
Prof. Andrea Gallamini, Department of Research, Innovation and Statistics, A. Lacassagne Cancer Centre, Nice France, Italy
Prof. Augusto Federici, Università di Milano, Italy
Prof. Antonio Gasbarrini, Università Cattolica
Prof. Luigi Maria Larocca, Catholic University, Rome, Italy
Prof. Richard A. Larson, University of Chicago, United States
Prof. Luca Laurenti, pol. a gemelli, Italy
Prof. Mario Luppi, Dip.Oncoematologia Università di Modena
Prof. Francesco Lococo, Università di Roma TorVergata, Roma, Italy
Prof. Alberto Matteelli, Institute of Infectious and Tropical Diseases, University of Brescia, 1-25123 Brescia, Italy. Electronic address:, Italy
Prof. Cristina Mecucci, University of Perugia, Italy
Prof Giovanna Meloni, Italy
Prof. Raffaella Origa, Clinica Pediatrica 2°, Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Università di Cagliari, Ospedale Regionale per le Microcitemie, ASL 8 Cagliari, Italy
Prof. Livio Pagano, Università Cattolica, Italy
Prof. Fabrizio Pane, Departments of Biochemistry and Medical Biotechnology, Federico II University Medical School, Naples, Italy., Israel
Dr. Maria Teresa Petrucci, Sapienza University of Rome, Italy
Prof. Eligio Pizzigallo, "G. d'Annunzio" University of Chieti (IT), Italy
Prof. Alessandro Rambaldi, University of Milan, Ospedale Papa Giovanni XXIII, Bergamo, Italy
Dr. Francesco Rodeghiero
Prof. Miguel A. Sanz, Hospital Universitario La Fe Servicio de Hematología Valencia, Spain, Spain
Prof. Corrado Tarella, Department of Biotechnology and Life Sciences, University of Torino, Torino, Italy, Hematology and Cell Therapy Division, Mauriziano Hospital, Torino, Italy
Prof. Adriano Venditti, Università Roma Torvergata, Italy
Dr. Giuseppe Visani, Ospedale S. Salvatore, Pesaro. Italy
Prof. Maria Teresa Voso, Università di Roma Torvergata, Italy
|
